Member Info for fish2

What can go wrong is major pharma’s lobbying with politicians and the members of SAGE in their pay.
To buy big pharma isn’t a risk for politicians and SAGE even if it doesn’t work. The vaccines are being funded with billions of our money by the government as that’s what the media want and the politicians follow the media like sheep.

Thanks

Yes I saw that recruitment had been slow but they extended it from the Southampton area to the whole country. Then no comment in his latest interview although he wasn’t asked the question.

In his interview RM wasn’t asked :

1. Are they managing to fill the at home trial? Need 120 volunteers who risk getting the placebo!
2. How does the Peer Review work. Who reviews and is there urgency in doing this and has the data been released for the peer review.

The iron ore price ($128/ton) means that IRC should be generating substantial cash. They have cleared the hedging contracts so get the full benefit. Production appears to be at 90% of capacity.
This will soon become an asset rather than a potential black hole.
I hope the new Board don’t have to sell at the knockdown price agreed by the old management.
The guarantee generates a nice little extra for POG.
This is a major turnaround that’s not in POG’s SP.
Interesting to see what they say about IRC when interims are published.

I do not understand why the government is pushing vaccines which will take a longtime to be available rather than medication to alleviate the worst effects of the Covid 19 virus.
Despite its proven ( in a small sample) safety and effectiveness it appears SNG aren’t getting any government help and are being left to do everything themselves.

To neutralise the worst effects would save the NHS and allow the country to get back to normal now.
As a COPD sufferer I would ask for SNG001 which I believe has the best chance of stopping the virus getting into my lungs.

I’ve been a shareholder for 5 years following the company and believe in their product.

Last accounts 56% GM.
3x TLY.’s 18%.

I think you’ll find the margins are rather different.

TW maybe right about the past but what is interesting non-exec Gavin Mayhew subscribed £150k out of £500k raised in Feb. So non-execs (or at least Gavin Mayhew) didn’t know company presentations were misleading as to actual sales.
Then CEO & FD changed - maybe the reason was the misleading RNS.
THIS IS NOW A NEW COMPANY AND IN A SWEET SPOT.
The past performance isn’t an indicator of the future in this case.

Yes and missed Monday. Well done all friday’s buyers.

It surprised me there was no growth in sales in the qtr ending June 30th compared to 2019. Given Covid you would have expected a jump and if sales don’t increase the net bottom line won’t change.

You have bought the right to buy the shares at 47p until November.
After November your rights lapse if you’ve not bought which you wouldn’t do if the price is below 47p.
You can sell your rights in the market anytime until November.
If you didn’t understand this you shouldn’t be buying.

Hi Hardcore
I am on the list to join a trial if I catch the virus.
My personal worry is I am given the placebo rather than SN001.
Having heard Richard Marsden present and been a shareholder for years as a COPD sufferer I have followed the shares and believe in the product.
Do you have an in so I can get the real thing if required?

Great RNS - they are planning to wind up the Trust and realise full value.
Should increase substantially in the meantime the share buyback programme.

DO NOT REPLY Stanhope Mews Surgery is supporting a clinical trial exploring treatment for COVID-19. If you currently feel unwell with a new/worsening cough or high temp temperature and have had it for less than 14 days and are not starting to feel better, please click https://sentry.phc.ox.ac.uk/sentry/principle/live/survey/open?id=screening&sc=SMW to find out more, or call the Trial Team on 0800 138 0880 if you do not have online access.

Thanks for the detail.
My interest is my old diesel car isn’t ULEZ compliant and as I live in west London I have no choice but to buy a new car.
My diesel will do 500+ miles with 50 litres. An electric goes nowhere - on average when I drive it’s between 200 and 500 miles - Wales, Cornwall, Scotland and a house in the Loire valley.
Thought hybrid the answer but they don’t recharge the battery when using petrol and range on motorways no more than pure electric.
I’m coming back to the view a modern diesel is the only way to go. Normally I like to buy a good quality secondhand car that I then drive for at least 10 years.
If there was some sort of network I would think of hydrogen.

What I don’t understand is : Can the hydrogen be shipped to future filling stations like petrol or does each station have have its own electrolyser.
If so why isn’t it being rolled out by Shell and Honda so we can buy hydrogen cars that refuel quickly and have a good range unlike electric cars.

Maybe they are waiting to announce IRC sale with the results.

Yes it appears so but find it difficult to believe a reputable house behave so.
The unilateral dividend announcement after they knew a bid was being considered is not good and could be construed as trying to force the hand of the Board.
Maybe the best way out of this is to wind up the Trust over the next 18 months as the loans are paid down. Then shareholders get the full NAV.

Will the offer survive this nonsense ?

Hope so but SP down substantially this morning reflecting worries about what happens if the bid doesn’t materialise.

I suppose Pollen Street can’t disclose borrowers’ Confidential financial information to 3rd parties.

Today’s RNS says up to £10m. So £0 to £10m - no commitment from buyer. What’s Bidstack’s share - ?????? 1%.
Billings and Revenue are 2 different things.
If it was real it would have taken longer to agree.